Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid for IVF Failure with Positive NK Cells
NCT01916798Phase 3Terminated
- Sponsor
- Cairo University
- Start
- May 2013
- Primary completion
- Jan 2015
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Intralipid 10% in infertility, recurrent miscarriage (RPL), Repeated Implantation Failure (RIF), sponsored by Cairo University. Started May 2013; status: terminated.
02
Drugs
Intralipid 10%
03
Conditions
infertilityrecurrent miscarriage (RPL)Repeated Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT01916798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01916798.